NEW YORK – The Affordable Care Act (ACA) will be repealed, PDUFA VI will almost certainly be passed and the pressure on drug pricing will not go away in the coming year. While panelists during a panel on policy outlook under the new Trump administration largely agreed on those predictions, some noted that gaining a bit of certainty could be the biggest boon for the industry in 2017.